- Home
- ECX vs EBS Comparison
ECX vs EBS Comparison
Compare ECX & EBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ECX | EBS |
|---|---|---|
| Founded | 2017 | 1998 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 643.6M | 625.0M |
| IPO Year | N/A | 2006 |
Fundamental Metrics
Financial Performance| Metric | ECX | EBS |
|---|---|---|
| Price | $1.60 | $12.33 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | $3.20 | ★ $15.00 |
| AVG Volume (30 Days) | ★ 3.4M | 848.8K |
| Earning Date | 11-03-2025 | 10-29-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 1.35 |
| Revenue | ★ $822,663,229.00 | $788,900,000.00 |
| Revenue This Year | $772.81 | N/A |
| Revenue Next Year | $30.47 | $15.21 |
| P/E Ratio | ★ N/A | $8.45 |
| Revenue Growth | ★ 6.99 | N/A |
| 52 Week Low | $0.76 | $4.02 |
| 52 Week High | $3.25 | $13.41 |
Technical Indicators
Market Signals| Indicator | ECX | EBS |
|---|---|---|
| Relative Strength Index (RSI) | 38.64 | 64.02 |
| Support Level | $1.71 | $11.34 |
| Resistance Level | $2.16 | $12.28 |
| Average True Range (ATR) | 0.12 | 0.50 |
| MACD | -0.01 | 0.05 |
| Stochastic Oscillator | 1.77 | 97.18 |
Price Performance
Historical ComparisonAbout ECX ECARX Holdings Inc. Ordinary shares
ECARX Holdings Inc is engaged in the sales of system-on-chip core modules, automotive computing platform products, and software stacks as well as the provision of research and development services in the People's Republic of China. The company's core products include infotainment head units, digital cockpits, vehicle chip-set solutions, a core operating system, and an integrated software stack. Beyond this, ECARX is developing a full-stack automotive computing platform. It is engaged in automotive intelligence and networking.
About EBS Emergent Biosolutions Inc.
Emergent BioSolutions Inc offers public health products to the government and healthcare providers. Company operates in three segments namely Commercial Product, MCM Products, and Services segment. The Commercial Product Segment consisting of Nasal Spray; the MCM Products Segment consisting of Anthrax-MCM products, Smallpox-MCM products and Other Products and the Services Segment consisting of Bioservices portfolio. The key revenue is generated through the commercial segment which consists of NARCAN and other commercial products.